Belpointe Asset Management’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $23.7K | Sell |
|
|||||
2024
Q4 | $67.8K | Hold |
|
|||||
2024
Q3 | $58K | Sell |
|
|||||
2024
Q2 | $39.7K | Sell |
|
|||||
2024
Q1 | $33.6K | Sell |
|
|||||
2023
Q4 | $134K | Sell |
|
|||||
2023
Q3 | $196K | Sell |
|
|||||
2023
Q2 | $277K | Sell |
|
|||||
2023
Q1 | $241K | Sell |
|
|||||
2022
Q4 | $244K | Sell |
|
|||||
2022
Q3 | $529K | Sell |
|
|||||
2022
Q2 | $345K | Buy |
|
|||||
2022
Q1 | $271K | Buy |
|
|||||
2021
Q4 | $876K | Sell |
|
|||||
2021
Q3 | $1.11M | Sell |
|
|||||
2021
Q2 | $1.59M | Sell |
|
|||||
2021
Q1 | $1.65M | Sell |
|
|||||
2020
Q4 | $1.59M | Sell |
|
|||||
2020
Q3 | $2.23M | Sell |
|
|||||
2020
Q2 | $3.18M | Sell |
|
|||||
2020
Q1 | $1.75M | Sell |
|
|||||
2019
Q4 | $4.59M | Sell |
|
|||||
2019
Q3 | $5.06M | Sell |
|
|||||
2019
Q2 | $6.23M | Sell |
|
|||||
2019
Q1 | $5.73M | Buy |
|